Skip to content

Buttermilk as a source of protective glycolipids

    Artistic impression of a plasma membrane of a human cell. People who have insufficient glycolipids in their intestines are prone to disease, but buttermilk made from colostrum may remedy this issue.

    Written by: Daniela Barile, Ph.D., Hyeyoung Lee | Issue # 8 | 2012

    • Healthy human intestines are coated with protective glycolipids.
    • People with intestinal inflammation/diseases don’t have enough of these glycolipids.
    • Milk is the only known food source for the glycolipids.
    • Buttermilk made from colostrum could potentially provide a concentrated source.

    Is fat really bad for you? Or could some fat actually be good for your tummy? The common answer might be “That’s impossible.” But is it? It turns out that one type of milk fat only recently being studied may be especially beneficial for intestinal health. Here is the story.

    The human intestinal surface is covered with a layer of complex sugars that act in part as signaling molecules. That is, they transmit information between the cells of multi-cellular organisms. In the sugar layer of the intestines, there are abundant membrane lipids also covered with sugars, and they represent 30-40% of total lipids in the intestinal mucosa. These hybrid molecules that contain both lipids (fat) and glycans (carbohydrates) are called glycolipids. Although originally discovered in the brain, glycolipids are found in virtually every vertebrate tissue, but are especially abundant on the surface of intestinal mucosa.

    Recent observations from animal studies show that an inflamed intestinal mucosa has lost many of those glycolipids compared to a healthy intestinal mucosa [1]. Unfortunately, the rapid degradation of glycolipids in the intestine, typical of inflammatory intestinal diseases, is associated with a further increase in pro-inflammatory signaling, inflammatory markers, and susceptibility to pathogens. Conditions like necrotizing enterocolitis (in infants), inflammatory bowel diseases, and Crohn’s disease (in adults) are becoming a new health problem, affecting over 1 million Americans each year. Because neither surgical nor drug interventions cure these diseases, there are increasing demands for new treatments.

    One clinical study has already shown the positive role of dietary glycolipids in pre-term infants using glycolipids extracted from porcine brain [2].  However, the estimated average intake of glycolipids by a population not consuming brains is below levels believed to provide therapeutic benefit.  Could these precious glycolipids be extracted from brains? Not without exhaustive safety testing that would require decades of investment. A limiting factor in moving this field to the marketplace is the inability to find commercially viable sources of these materials that will allow researchers to move into clinical trials and demonstrate in vivo bioactivities.

    So, researchers are asking the new question: is it possible to find glycolipids, identical to our protective lipids in the intestinal mucosa, in the food that we eat? Could these dietary glycolipids replace those lost during development inflammatory diseases and re-establish the protective activity? The initial answer is: it appears to be indeed possible.

    Glycolipids are also found in milk. The positive effects from nutritional supplementation of glycolipids’ in newborns are most likely related to the prebiotic functions of glycolipids, as well as their contribution to an intestinal immune response and service as decoys for toxins [3]. Milk glycolipids have been studied for several years by researchers worldwide; despite their importance to health, isolating them and analyzing their structure is exceptionally challenging. Only recently have we acquired the ability to really understand their structure in detail and to prove that they are identical to the intestinal membrane glycolipids [4]. New results from data collected through advanced mass spectrometry indicate that milk glycolipids have the same structure as those in the human intestinal mucosa, GM3 (NeuAcα2-3Galβ1-4Glcβ-Cer) and GD3 (NeuAcα2-8NeuAcα2-3Galβ1-4Glcβ-Cer), respectively. Therefore, restoring proper glycolipid abundance and function in the intestine through the consumption of milk could resolve inflammation, increase resistance to infection, and improve gut integrity to induce remission of all gut inflammatory diseases.

    Will drinking store bought milk provide the desired benefits?  The answer to that question is, unfortunately, no. The amount of glycolipids in store-bought milk is too low to elicit bioactive action. However, there is another possibility for recovering and concentrating these molecules from milk.

    During industrial milk processing, the fat is disrupted and, as a result, the glycolipids move from the “fat” part of the milk to the “watery” part of the milk. When butter is made, the “watery” part is a byproduct that can then be used to make buttermilk.  It is from this buttermilk that glycolipids could be extracted. It turns out that buttermilk can also be produced from colostrum – the early milk – that is naturally richer in glycolipids compared to mature milk. Colostrum contains as much as 63 mg/kg of glycolipids [5].  Therefore, buttermilk made from colostrum could be a rich source of glycolipids.

    If buttermilk were to be used in clinical studies to demonstrate enhanced quality of life for people suffering from intestinal diseases, it could become the new star of the dairy industry!


    1. Park EJ, Suh M, Ramanujam K, Steiner K, Begg D, Clandinin MT. (2005) Diet-induced changes in membrane gangliosides in rat intestinal mucosa, plasma and brain. J Pediatr Gastroenterol Nutr. 40: 487-95.

    2. Rueda R, Sabatel JL, Maldonado J, Molina-Font JA, Gil A. (1998) Addition of gangliosides to an adapted milk formula modifies levels of fecal Escherichia coli in preterm newborn infants. J Pediatr. 133: 90-4.

    3. Rueda R. (2007) The role of dietary gangliosides on immunity and the prevention of infection. Br J Nutr. 98 Suppl 1: S68-73.

    4. Lee H, An HJ, Lerno LA, Jr., German JB, Lebrilla CB. (2011) Rapid profiling of bovine and human milk gangliosides by matrix-assisted laser desorption/ionization fourier transform ion cyclotron resonance mass spectrometry. Int J Mass Spectrom. 305: 138-150.

    5. Lee H, Barile D, Lebrilla CB, German JB. (2012) High-throughput quantitative analysis of bovine milk gangliosides by ultra-high performance liquid chromatography-tandem mass spectrometry. American Society of Mass Spectrometry (Vancouver, British Columbia).